The stock of biotechnology firm Intellia Therapeutics has experienced a severe downturn after US regulators imposed a ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

Allied Market Research published a report, titled, 'Cystic Fibrosis (CF) Therapeutics Market - Global Opportunity Analysis ...

Gloo is a Boulder, Colorado-based firm that offers technology tools to Christian churches and other faith groups. The company ...

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that ...